STAT3 and neoplasm: As mentioned, niclosamide has been recently identified as the small molecule inhibitor of STAT3 [34,35], the member of a signaling pathway that regulates many cellular processes important for tumorigenesis, including cell proliferation, cell cycle progression, apoptosis, or tumor angiogenesis [39].